The pathophysiological features of traumatic brain injury (TBI) include primary brain injuries, which are difficult to predict, and secondary brain injury. 1,2 Over the course of TBI, neuronal apoptosis occurs through a complex sequence of pathological events that involve several contributing factors, such as excitotoxicity, excitotoxic damage, mitochondrial dysfunction and autophagy. 3 Among these events, inflammation is an important factor that aggravates nerve injury during the process of secondary insult. Although the exact mechanisms responsible for the occurrence of neuronal insult and their final degeneration are equivocal, vast literature suggests an important role of neuroinflammation. 4,5 Cytokine signalling and inflammasome are linked to the 'redox-sensitive' master transcriptional regulator nuclear factor-kappa B (NF-κB). Indeed, activation of NF-κB causes an increase in the interleukin (IL)-1 level, which promotes the cascade of inflammatory factors in microglia (ie TNFα) and astrocytes (ie IL-6). 6,7 Accordingly, restrained activation of NF-κB reduces the neuroinflammatory process, which can prevent neuronal apoptosis. 8 Sirtuin 1 (SIRT1), also known as nicotinamide adenine dinucleotide (NAD)-dependent deacetylase sirtuin-1, contributes to cellular regulation (reaction to stressors and longevity). 9 It is a highly conserved and well-characterized NAD-dependent class III histone deacetylase in mammalian cells. Numerous studies have demonstrated that SIRT1 plays a central role in the regulation of different biological processes, such as mitochondrial biogenesis, oxidation and inflammation. [10][11][12] SIRT1 is activated in many central nervous system diseases, such as subarachnoid haemorrhage and Parkinson's disease. 13 In addition, it has been reported that it is an important